CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 2,642 shares at $32.57 ($86,050)
- 4 Planned sale Chief Financial Officer sold 672 shares at $32.57 ($21,887)
- 4 Planned sale Principal Accounting Officer sold 1,214 shares at $32.57 ($39,540)
- 4 Planned sale Chief Executive Officer sold 4,156 shares at $32.57 ($135,361)
- 4 Planned sale Chief Legal Officer sold 2,642 shares at $32.57 ($86,050)
- 4 Derivatives Options or other derivatives
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 69,329 shares at an average $34.67 ($2,403,592)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 68,142 shares at an average $33.09 ($2,254,951)
- 144 Insider Sale of Securities
- 4 Open-market sale Principal Accounting Officer sold 504 shares at $26.63 ($13,422)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale Chief Medical Officer sold 642 shares at $25.14 ($16,140)
- 4 Planned sale Chief Legal Officer sold 545 shares at $25.14 ($13,701)
Page 13 of 66 · 1,304 filings